Extract from the Register of European Patents

EP About this file: EP4225217

EP4225217 - DEVICE FOR TREATING VALVULAR INSUFFICIENCY [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  29.05.2025
Database last updated on 09.04.2026
FormerGrant of patent is intended
Status updated on  27.01.2025
FormerRequest for examination was made
Status updated on  14.07.2023
FormerThe international publication has been made
Status updated on  16.04.2022
Most recent event   Tooltip30.01.2026Lapse of the patent in a contracting state
New state(s): PL, RS
published on 04.03.2026  [2026/10]
Applicant(s)For all designated states
Coramaze Technologies Ltd.
7 Motta Gur Street
Petach-Tikva 4952801 / IL
[2023/33]
Inventor(s)01 / HARARI, Boaz
5592535 Ganei Tikva / IL
02 / SADAN, Ido
6813936 Tel-Aviv / IL
03 / GERHARDT, Thomas
7806 Cape Town / ZA
 [2023/33]
Representative(s)Sonnenberg Harrison Partnerschaft mbB
Herzogspitalstraße 10a
80331 München / DE
[2025/27]
Former [2023/33]Schmidt, Alexander
Sonnenberg Harrison Partnerschaft mbB
Herzogspitalstraße 10a
80331 München / DE
Application number, filing date21877142.607.10.2021
[2023/33]
WO2021IL51206
Priority number, dateUS202063089587P09.10.2020         Original published format: US 202063089587 P
[2023/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022074655
Date:14.04.2022
Language:EN
[2022/15]
Type: A1 Application with search report 
No.:EP4225217
Date:16.08.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 14.04.2022 takes the place of the publication of the European patent application.
[2023/33]
Type: B1 Patent specification 
No.:EP4225217
Date:02.07.2025
Language:EN
[2025/27]
Search report(s)International search report - published on:US14.04.2022
(Supplementary) European search report - dispatched on:EP13.03.2024
ClassificationIPC:A61F2/24
[2023/33]
CPC:
A61F2/246 (EP,IL,US); A61F2/2433 (US); A61F2/2466 (EP,IL,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/33]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VORRICHTUNG ZUR BEHANDLUNG VON KLAPPENINSUFFIZIENZ[2023/33]
English:DEVICE FOR TREATING VALVULAR INSUFFICIENCY[2023/33]
French:DISPOSITIF DE TRAITEMENT D'INSUFFISANCE VALVULAIRE[2023/33]
Entry into regional phase09.05.2023National basic fee paid 
09.05.2023Search fee paid 
09.05.2023Designation fee(s) paid 
09.05.2023Examination fee paid 
Examination procedure09.05.2023Examination requested  [2023/33]
18.07.2024Amendment by applicant (claims and/or description)
18.07.2024Date on which the examining division has become responsible
28.01.2025Communication of intention to grant the patent
28.05.2025Fee for grant paid
28.05.2025Fee for publishing/printing paid
28.05.2025Receipt of the translation of the claim(s)
Divisional application(s)EP25186583.8  / EP4620434
Fees paidRenewal fee
25.10.2023Renewal fee patent year 03
25.10.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ02.07.2025
HR02.07.2025
PL02.07.2025
NO02.10.2025
RS02.10.2025
GR03.10.2025
IS02.11.2025
[2026/10]
Former [2026/09]CZ02.07.2025
HR02.07.2025
NO02.10.2025
GR03.10.2025
IS02.11.2025
Former [2026/08]HR02.07.2025
NO02.10.2025
IS02.11.2025
Former [2026/07]IS02.11.2025
Documents cited:Search[XAYI] US2019083238  (NATHE NIKLAS MAXIMILIAN et al.) [X] 1,2,4,11,13,14 * figures 3,4,7A,7B * * paragraphs [0039] , [0091] , [0097] , [0098] *[A] 6-10 [Y] 3 [I] 5,12,15
 [Y] US2013046376  (HASSAN ALI et al.) [Y] 3 * figure 15 * * paragraph [0122] *
 [X] US2019247190  (NATHE NIKLAS MAXIMILIAN et al.) [X] 1 * figures 1,3,4 *
 [A] WO2020197854  (EDWARDS LIFESCIENCES CORP et al.) [A] 1,5 * figure 30 *
International search[XYA] US2019083238  (NATHE NIKLAS MAXIMILIAN et al.) [X] 1-2, 5-6, 12-17, 23, 25 * , . entire document *[Y] 3-4, 18-22, 24 [A] 7-11
 [YA] US2013046376  (HASSAN ALI et al.) [Y] 3-4 * , entire document *[A] 7-11
 [Y] WO2019011390  (CORAMAZE TECH GMBH et al.) [Y] 18 * , entire document *
 [Y] WO2018050202  (CORAMAZE TECH GMBH et al.) [Y] 19 * , entire document *
 [Y] US2014277404  (WILSON JONATHAN E et al.) [Y] 20, 24 * , entire document *
 [Y] US2016270910  (BIRMINGHAM EVELYN et al.) [Y] 21-22 * , entire document *
 [A] US2019076247  (ZENG QINGGANG et al.) [A] 1-25 * , entire document *
 [A] US2006058871  (ZAKAY AVRAHAM et al.) [A] 1-25 * , entire document *
 [A]   YARTSEV ALEX: "Normal saline, and why it is anything but "normal" ", DERANGED PHYSIOLOGY, 8 January 2020 (2020-01-08), XP055933859, Retrieved from the Internet [retrieved on 20220621] [A] 20, 24 * , entire document *
by applicantUS2019083238
 US2013046376
 US2019247190
 WO2020197854
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.